IRCT20180301038906N1
Completed
Phase 3
Adjunctive Memantine Therapy for Negative Symptoms in Schizophrenia: A Double-Blind Placebo Controlled Study
Overview
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 60
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •Schizophrenia in the relative recovery period
- •Use of atypical antipsychotics including risperidone and olanzapine
- •No other drugs (except anticholinergic and benzodiazepine)
- •Lack of pregnancy or breastfeeding
- •No serious organic disease and no drug use at the time of entering the study
Exclusion Criteria
- •There is serious organic disease
- •Pregnancy or breastfeeding
- •Existence of dementia
Investigators
Similar Trials
Recruiting
Not Applicable
Memantine for treatment of Obsessive-Compulsive DisorderIRCT20170123032145N4Iran University of Medical Sciences44
Completed
Phase 2
Memantine in the treatment of obsessive-compulsive disorderIRCT201106031556N22Tehran University of Medical Sciences40
Completed
Not Applicable
Memantine add on to treatment of refractory obssessive compulsive disorder: A double-blind clinical trialObsessive- Cumpulsive Disorder.Obsessive-compulsive disorderIRCT138712141743N1Research Center for Behavioral Disorder and Substance Abuse, Hamadan University of Medical Sciences72
Recruiting
Phase 2
Study of the efficacy of memantine in metastatic colon canceIRCT20210819052230N1Oroumia University of Medical Sciences50
Completed
Not Applicable
Evaluating the Effectiveness of Memantine on the Symptoms of Acute Mania in the Patients with Bipolar 1 DisorderBipolar I disorder.Bipolar affective disorder, current episode hypomanicIRCT2016121725031N6Vice Chancellor for Research of Arak University of Medical Sciences90